Abstract
Lichens have exhibited numerous biological activities, including growth inhibition of tumor cells. This study evaluated the antiproliferative activity of hypostictic and salazinic acids against tumor cell lines (B16-F10, PC-03, MCF7, HT-29, HEP-G2, K562 and 786-0) by the SRB assay in vitro and antitumor activity in experimental murine melanoma in vivo. Activation of caspase-3 was quantified by flow cytometry. The murine experimental melanoma model B16-F10 was used in BALB/c mice for evaluation of antitumor activity. Hypostictic acid showed significant antiproliferative activity in K562 cells (GI50 2.20μM), B16-F10 (GI50 13.78μM) and 786-0 (GI50 14.24μM), whereas salazinic acid was more active against K562 cells (GI50 64.36μM), HT-29 (GI50 67.91μM) and B16-F10 (GI5078.64μM). Quantification of capase-3 revealed that the test compounds did not increase the expression of that enzyme. In the in vivo antitumor evaluation in B16-F10 melanoma, the isolated compounds inhibited tumor growth in relation to weight and volume. Hypostictic acid (16.7mg/kg) inhibited 72% and salazinic acid 88% of tumor volume (p<0.05). The results indicated that, both in the in vitro and in vivo models, the compounds evaluated showed antiproliferative and antitumor activities.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have